Science Explorer Back to mapMap
Discussion
Hospital / health system · Preston · United Kingdom

Rosemere Cancer Foundation

rosemere.org.ukROR OpenAlex
Research works
5
▲ 220% vs 2018-21
Citations
31
5.8 per fractional work
Top-10% rate
8.5%
all institutions 10.0%
Open access
13%
world 40%
International
6%
world 18%
Rosemere Cancer Foundation

Not ranked overall: Rosemere Cancer Foundation is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Rosemere Cancer Foundation work in?

In all years, 77% of research at Rosemere Cancer Foundation is in Health Sciences, 20% in Physical Sciences. Its largest fields are Medicine (77%), Physics and Astronomy (12%), Engineering (8%). It does 1.7× the world's share of Health Sciences.

Health Sciences: 4 fractional works · 77.2% of its workMedicine: 4 fractional works · 77.2% of its workPulmonary and Respiratory Medicine: 1 fractional works · 26.0% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 18.2% of its workOncology: 1 fractional works · 17.6% of its workOtorhinolaryngology: 0 fractional works · 6.1% of its workSurgery: 0 fractional works · 5.6% of its workUrology: 0 fractional works · 2.0% of its workGenetics: 0 fractional works · 1.5% of its workPhysical Sciences: 1 fractional works · 20.2% of its workPhysics and Astronomy: 1 fractional works · 12.4% of its workNuclear and High Energy Physics: 0 fractional works · 6.1% of its workRadiation: 0 fractional works · 6.1% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEngineering: 0 fractional works · 7.8% of its workElectrical and Electronic Engineering: 0 fractional works · 6.1% of its workBiomedical Engineering: 0 fractional works · 1.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workLife Sciences: 0 fractional works · 2.2% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 2.2% of its workCancer Research: 0 fractional works · 1.5% of its workMolecular Biology: 0 fractional works · 0.9% of its workSocial Sciences: 0 fractional works · 0.4% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workALL ITS WORKRosemere CancerFoundation5fractional works, all years
Life Sciences2%Physical Sciences20%Health Sciences77%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 5 fields, with their numbers
    1. Medicine477.2%
    1. Physics and Astronomy112.4%
    2. Engineering07.8%
    1. Biochemistry, Genetics and Molecular Biology02.2%
    1. Economics, Econometrics and Finance00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Rosemere Cancer Foundation?

The most cited paper from Rosemere Cancer Foundation is "EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees" (Alan Horwich et al., 2019), with 183 citations. Next come "CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations" (165) and "Exploring the decision‐making preferences of people with colorectal cancer" (80).

Most cited papers
#PaperReleasedCitations
1 EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees Alan Horwich et al. · Annals of Oncology Open access121 authors 30 Aug 2019 183
2 CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations Enriqueta Felip et al. · European Journal of Cancer Open access 2 Feb 2020 165
3 Exploring the decision‐making preferences of people with colorectal cancer Kinta Beaver, David John Jones, Shabbir S. Susnerwala et al. · Health Expectations Open access 28 Apr 2005 80
4 Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial Hannah L. Rush et al. · Journal of Clinical Oncology Open access 10 Nov 2021 64
5 Health economic evaluation of a serum-based blood test for brain tumour diagnosis: exploration of two clinical scenarios Ewan Gray, Holly J. Butler, Ruth Board et al. · BMJ Open Open access May 2018 58
All 17 most cited papers, with filters and sorting

Which research topics does Rosemere Cancer Foundation publish most on?

By volume in 2022-now: Radiopharmaceutical Chemistry and Applications, Head and Neck Cancer Studies, Gastric Cancer Management and Outcomes and Lung Cancer Research Studies.

Radiopharmaceutical Chem…0Radiopharmaceutical Chemistry and Applications: 0 fractional worksHead and Neck Cancer Stu…0Head and Neck Cancer Studies: 0 fractional worksGastric Cancer Managemen…0Gastric Cancer Management and Outcomes: 0 fractional worksLung Cancer Research Stu…0Lung Cancer Research Studies: 0 fractional worksProstate Cancer Treatmen…0Prostate Cancer Treatment and Research: 0 fractional worksCancer Diagnosis and Tre…0Cancer Diagnosis and Treatment: 0 fractional worksBrain Metastases and Treatment: 0 fractional worksNanoplatforms for cancer theranostics: 0 fractional worksGlioma Diagnosis and Treatment: 0 fractional worksBladder and Urothelial Cancer Treatments: 0 fractional works
Radiology, Nuclear Medicine and ImagingOtorhinolaryngologyPulmonary and Respiratory MedicineOncology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  2. 2 Head and Neck Cancer Studies Otorhinolaryngology 0 works
  3. 3 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
  4. 4 Lung Cancer Research Studies Oncology 0 works
  5. 5 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 0 works
  6. 6 Cancer Diagnosis and Treatment Oncology 0 works
  7. 7 Brain Metastases and Treatment Pulmonary and Respiratory Medicine 0 works
  8. 8 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  9. 9 Glioma Diagnosis and Treatment Genetics 0 works
  10. 10 Bladder and Urothelial Cancer Treatments Surgery 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available13.2%not open86.8%

World: 40% of research is openly available.

with international co-authors6.4%domestic only93.6%

World: 18% is written across borders.

How has Rosemere Cancer Foundation's research output changed?

Output in 2022-2025 was 220% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Rosemere Cancer Foundation as a percentage of every work published that year, 0.0000084% in 2022.

still counting0.000020%0.000040%0.000060%Rosemere Cancer Foundation0.000018% in 202520102020

Fractional works of Rosemere Cancer Foundation over all fractional works that year. How the balance of science has shifted.

Other research institutions in Preston

All research institutions in Preston

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Rosemere Cancer Foundation. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.